Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthes Spine Gains HDE Approval For Pediatric Titanium Rib Device

This article was originally published in The Gray Sheet

Executive Summary

Synthes Spine is weighing whether to pursue premarket application approval for the Vertical Expandable Prosthetic Titanium Rib (VEPTR) after obtaining a humanitarian device exemption

You may also be interested in...



Q&A: Surgeon Robert Campbell On Outcome Measures For Kids In Ortho Device Trials

Campbell, professor of orthopedic surgery at the Children's Hospital of Philadelphia, spoke with “The Gray Sheet” about the challenges tied to establishing effective measures for studies evaluating children with orthopedic devices, and other issues.

Feds Try To Pave Path For Frustrated Pediatric Device Innovators

The National Institutes of Health and other government agencies will submit plans to Congress next month on how to encourage the development of medical devices designed specifically with children in mind. Innovators say having a clear path could make a difference, but the challenges of getting support for a pediatric project all the way to market remain steep

Feds Try To Pave Path For Frustrated Pediatric Device Innovators

The National Institutes of Health and other government agencies will submit plans to Congress next month on how to encourage the development of medical devices designed specifically with children in mind. Innovators say having a clear path could make a difference, but the challenges of getting support for a pediatric project all the way to market remain steep

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel